Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
6.59
-0.03 (-0.45%)
May 13, 2025, 4:00 PM - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $138.63 million as of May 14, 2025. Its market cap has decreased by -47.90% in one year.
Market Cap
138.63M
Enterprise Value
43.90M
1-Year Change
-47.90%
Ranking
Category
Stock Price
$6.59
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $138.63M, an increase of 52.18%. That is a compound annual growth rate of 9.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 138.63M | -21.42% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |